The role of the gene 71 product in the life cycle of equine herpesvirus 1.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
The research investigates the function of the gene 71 product in the lifecycle of Equine herpesvirus type 1 (EHV-1). The researchers found out that the mutation of gene 71 impacted the process of viral maturation and capsid envelopment, resulting in decreased virus absorption/penetration and subsequent propagation via direct cell-to-cell contact.
Introduction
Equine herpesvirus type 1 (EHV-1) is a common viral infection in horses. An aspect of its genetic makeup is a gene known as gene 71. The protein encoded by gene 71 does not share a resemblance with any identified herpesvirus homologues and is characterized as a 192 kDa protein, heavily O-glycosylated. Prior to this research, a deletion mutant of this gene (ED71) was isolated, proving gene 71 and its protein product are not essential in vitro. The aim of this study is to examine gene 71’s role in the EHV-1 life cycle.
Methods
- The researchers used a mutation in gene 71 (identified as ED71) to examine the gene’s contribution to the virus life cycle. The effects on several stages of the virus lifecycle, including cellular adsorption, penetration, egress, and transmission, were noted.
- ED71 was compared with a wild-type and revertant virus to observe the differences in viral behavior and characteristics.
- The researchers also observed the number and ratio of enveloped to unenveloped capsids in ED71-infected cells compared to wild-type virus-infected cells.
- The impact of a neutralizing antiserum on ED71 plaque size was also assessed to gauge its effect on the mutant virus’s ability to spread via release and readsorption to uninfected cells.
Results
- The findings showed that ED71 virions exhibited less efficient cell adsorption than the wild-type and revertant virus, and consequently, the virus’s ability to penetrate cells was affected.
- Virus egress was significantly impaired in the ED71 variant and the timing of release was delayed, indicating a defect in virus maturation and capsid envelopment due to deletion of gene 71.
- The number of both full and empty capsids accumulating in the nuclei of ED71-infected cells was significantly higher than in wild-type virus-infected cells. Additionally, the most notable differences were observed in the low number of particles and low enveloped to unenveloped capsids ratio in the cytoplasm of ED71-infected cells.
- The reduced plaque size did not diminish even with the usage of a neutralizing antiserum, suggesting that deletion of gene 71 impaired the virus’s ability to spread via release and reabsorption to uninfected cells; therefore, mutant virus transmission mainly occurred via direct cell-to-cell contact.
Conclusion
The research concluded that the deletion of EHV-1 gene 71 results in a defect in virus maturation and capsid envelopment. Consequently, the virus’s progeny was observed to be impaired in absorption/penetration, presumably due to the deficiency of the glycoprotein spikes predicted to be encoded by gene 71, resulting in the virus’s propagation primarily via direct cell-to-cell contact.
Cite This Article
Publication
Researcher Affiliations
- Institute of Virology, University of Glasgow, UK.
MeSH Terms
- Animals
- Cell Line
- Cricetinae
- Herpesvirus 1, Equid / genetics
- Herpesvirus 1, Equid / physiology
- Mutation
- Viral Proteins / genetics
- Viral Proteins / physiology
- Virion / physiology
- Virus Replication / genetics
Citations
This article has been cited 6 times.- Trybala E, Peerboom N, Adamiak B, Krzyzowska M, Liljeqvist JÅ, Bally M, Bergström T. Herpes Simplex Virus Type 2 Mucin-Like Glycoprotein mgG Promotes Virus Release from the Surface of Infected Cells.. Viruses 2021 May 12;13(5).
- Wimer CL, Schnabel CL, Perkins G, Babasyan S, Freer H, Stout AE, Rollins A, Osterrieder N, Goodman LB, Glaser A, Wagner B. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.. PLoS One 2018;13(11):e0206679.
- Azab W, El-Sheikh A, Abdel-Gawad A. In vitro characterization of EHV-4 gG-deleted mutant.. Virus Genes 2012 Feb;44(1):109-11.
- Smith PM, Kahan SM, Rorex CB, von Einem J, Osterrieder N, O'Callaghan DJ. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.. J Virol 2005 Apr;79(8):5105-15.
- Fuchs W, Wiesner D, Veits J, Teifke JP, Mettenleiter TC. In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs.. J Virol 2005 Jan;79(2):705-16.
- von Einem J, Wellington J, Whalley JM, Osterrieder K, O'Callaghan DJ, Osterrieder N. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.. J Virol 2004 Mar;78(6):3003-13.